Luosheng Tang Selected Research

Luosheng Tang Research Topics

Disease

6	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 01/2014
5	Inflammation (Inflammations) 01/2019 - 07/2013
4	Macular Degeneration (Age-Related Maculopathy) 11/2023 - 09/2004
4	Neoplasms (Cancer) 11/2023 - 01/2017
3	Glaucoma 01/2016 - 04/2014
3	Ischemia 07/2014 - 11/2011
3	Hypoxia (Hypoxemia) 05/2013 - 06/2002
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2017 - 05/2010
2	Infections 01/2017 - 11/2016
2	Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy) 11/2016 - 11/2012
2	Dry Eye Syndromes (Dry Eye Syndrome) 02/2016 - 07/2015
2	Reperfusion Injury 07/2014 - 11/2011
2	Optic Nerve Injuries 01/2013 - 07/2011
1	Macular Edema 10/2021
1	Pathologic Neovascularization 01/2019
1	Retinal Neovascularization 01/2019
1	Carcinogenesis 06/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 06/2018
1	Retinoblastoma (Glioblastoma, Retinal) 06/2018
1	Neoplasm Metastasis (Metastasis) 06/2018
1	Retinal Degeneration 08/2017
1	Blindness (Hysterical Blindness) 01/2017
1	Metaplasia 02/2016
1	Retinoschisis (Retinoschisis, Juvenile) 01/2016
1	Burns 01/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2016
1	Lentivirus Infections 10/2015
1	Drug-Related Side Effects and Adverse Reactions 07/2015
1	Cataract (Cataracts) 01/2015
1	Demyelinating Diseases (Demyelinating Disease) 04/2014
1	Uveitis 07/2013
1	Arthralgia (Joint Pain) 07/2013
1	Dyspnea (Shortness of Breath) 07/2013
1	Back Pain (Backache) 07/2013
1	Fever (Fevers) 07/2013
1	Posterior Leukoencephalopathy Syndrome 11/2012
1	Hyperglycemia 06/2012
1	Type 2 Diabetes Mellitus (MODY) 06/2012
1	Crush Injuries 07/2011

Drug/Important Bio-Agent (IBA)

9	Retinaldehyde (Retinal)IBA 08/2017 - 06/2002
5	Proteins (Proteins, Gene)FDA Link 06/2018 - 12/2003
3	Metalloproteases (Metalloproteinases)IBA 06/2018 - 01/2015
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2014 - 12/2003
3	Advanced Glycation End ProductsIBA 05/2013 - 06/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2021 - 07/2013
2	CatalaseIBA 01/2016 - 11/2011
2	AntioxidantsIBA 01/2014 - 03/2012
2	Therapeutic UsesIBA 07/2013 - 07/2011
2	salicylhydroxamic acid (SHAM)IBA 01/2013 - 07/2011
2	Matrix Metalloproteinases (MMPs)IBA 09/2004 - 06/2003
1	afliberceptIBA 11/2023
1	Biosimilar PharmaceuticalsIBA 11/2023
1	Protein Isoforms (Isoforms)IBA 11/2023
1	tyrosine receptor (receptor, tyrosine)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2021
1	Competitive Endogenous RNAIBA 01/2019
1	Circular RNAIBA 01/2019
1	CytosineIBA 01/2019
1	CDC2 Protein Kinase (Protein p34cdc2)IBA 06/2018
1	H-cadherin (T-cadherin)IBA 06/2018
1	VimentinIBA 06/2018
1	Long Noncoding RNAIBA 06/2018
1	Levofloxacin (Levaquin)FDA Link 01/2017
1	Netrin-1IBA 01/2017
1	TOR Serine-Threonine KinasesIBA 11/2016
1	Sirolimus (Rapamycin)FDA Link 11/2016
1	Neuroprotective AgentsIBA 11/2016
1	Messenger RNA (mRNA)IBA 11/2016
1	Minocycline (Cyclops)FDA LinkGeneric 02/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2016
1	Initiator Codon (Start Codon)IBA 01/2016
1	Transfer RNA (tRNA)IBA 01/2016
1	Streptozocin (Streptozotocin)FDA Link 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 10/2015
1	Becaplermin (PDGF-BB)FDA Link 10/2015
1	Alitretinoin FDA Link 10/2015
1	Ophthalmic Solutions (Eye Drops)IBA 07/2015
1	Fluorescein (Funduscein)FDA LinkGeneric 07/2015
1	diquafosolIBA 07/2015
1	Hyaluronic Acid (Hyaluronan)IBA 07/2015
1	GATIBA 01/2015
1	KH902 fusion proteinIBA 09/2014
1	Endoplasmic Reticulum Chaperone BiPIBA 07/2014
1	IronIBA 04/2014
1	AldehydesIBA 04/2014
1	CalciumIBA 04/2014
1	Edetic Acid (EDTA)FDA Link 04/2014
1	LipidsIBA 04/2014
1	IonsIBA 04/2014
1	Prednisolone (Predate)FDA LinkGeneric 07/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 11/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2012
1	CytokinesIBA 07/2011

Therapy/Procedure

5	Therapeutics 06/2018 - 04/2014
3	Transplantation 01/2013 - 07/2011
1	Vitrectomy 01/2021
1	Lasers (Laser) 01/2016
1	Injections 09/2014
1	Glycemic Control 06/2012